FDC - 531599

Company	FDC
BSE	531599
NSE	FDC
Price	82.2
As of date	Feb 14, 14:55
Market Cap	1,506.64
PE	11.15
EPS	7.37
Div yield %	2.43%
Topline growth (5yr)	12.14%
Bottomline growth (5yr)	23.31%
Reserves	Reserves have increased from 311.63 to 592.86 from Mar '07 to Mar '11
Debt	Debt has decreased from 3.11 to 2.06 from Mar '07 to Mar '11
Shareholding	Promoters hold 66.64% of which -% are pledged
# of shares	18.33

Aurobindo Pharma Ltd - 524804

Name of Company	Aurobindo Pharma Ltd
BSE Code	524804
NSE Code
ICICI Code
Established	1986
My Take	So-So
Headquarters	Hyderabad
Promoters	PV Ramaprasad Reddy, Nithyananda Reddy
Story	Became public in 1995. Has agreements with Pfizer.
Sector	Pharma
Sub-sector	API, formulations
Website	http://www.aurobindo.com/
Positives	Revenues have more than doubled over 5 years. Regular, but very less dividend yields.
Negatives	2000 Cr loan according to FY10. 54% promoter shareholding 11% of that is pledged. NPMs are not very dependable. Seems like some insider trading also is happening.
Peers
News
Price @ blogged	1270 (13-Nov-10)
Cost of company	7400 Cr market cap for a 525Cr FY10 NP translates to 14 times. 1800 Cr reserves with a 2000 Cr debt.

Dishman Pharmaceuticals & Chemicals Ltd - 532526

Name of Company	Dishman Pharmaceuticals & Chemicals Ltd
BSE Code	532526
NSE Code	DISHMAN
ICICI Code
Established	1983
My Take	So-So
Headquarters	Ahmedabad
Promoters
Story	Facilities in Europe, India and China. Listed in 2004. Acquisitions brought CRAMS CARBOGEN AMCIS (Swiss) and IO3S (Swiss) into Dishman.
Sector	Pharma
Sub-sector	CRAMS, APIs
Website	http://www.dishmangroup.com/
Positives	Good NPMs at 16-19%. Shows 600 Cr reserves (which almost 45% of current market cap). Regular dividends, yields around 0.8% at current prices.
Negatives	434 Cr of debt in FY10. Revenue guidance revised to 10%. FY09 revenue and profit was bigger than FY10 numbers.
Peers	Shasun, Divi's lab, Nicholas Piramal
News
Price @ blogged	169(12-Nov-10)
Cost of company	1361 Cr market cap for a 71 Cr FY NP makes it less than 20 times. 434 Cr debt and lower revenue visibility makes it costly even with high NPM's.